MULTIPLY YOUR VOICE

SHARE

Regeneron Rallies After Seeking Emergency-Use Approval For Antibody Cocktail Hailed As "Cure" By Trump

Regeneron

“Shares of Regeneron are ripping higher Thursday in premarket trading, building on its gains from Wednesday evening, after the company submitted its COVID-19 antibody cocktail to the FDA for emergency-use approval. The news follows President Trump's full-throated endorsement of the therapy, which the president credited for his speedy recovery, calling the treatment a "cure" for COVID-19.”

https://www.zerohedge.com/markets/regeneron-rallies-after-seeking-emergency-use-approval-antibody-cocktail-taken-trump

Be the first to comment

Please check your e-mail for a link to activate your account.